Fig. 6From: MiR-489 inhibited the development of gastric cancer via regulating HDAC7 and PI3K/AKT pathwaymiR-489 modulated EMT and PI3K/AKT pathway. a E-cadherin, N-cadherin, and Vimentin protein levels in GC cells treated with miR-489 mimic, inhibitor, or combined with HDAC7 siRNA. *P < 0.05, **P < 0.01 vs. NC group; #P < 0.05 vs. miR-489 mimic group. b p-PI3K, PI3K, and p-AKT, AKT protein levels in GC cells treated with miR-489 mimic, inhibitor, or combined with HDAC7 siRNA. Western blots have been performed three times. *P < 0.05, **P < 0.01 vs. NC group; #P < 0.05 vs. miR-489 mimic groupBack to article page